Tyler-Stone Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4K Hold
10
– – ﹤0.01% 685
2022
Q3
$3K Hold
10
– – ﹤0.01% 711
2022
Q2
$4K Hold
10
– – ﹤0.01% 690
2022
Q1
$5K Hold
10
– – ﹤0.01% 670
2021
Q4
$7K Buy
+10
New +$6.28K ﹤0.01% 655

Other funds holding IDXX

Tyler-Stone Wealth Management's IDXX Position: Q4 2022 in Review

Tyler-Stone Wealth Management held its Idexx Laboratories (IDXX) position steady in Q4 2022 at 10 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Tyler-Stone Wealth Management first reported a position in IDXX in Q4 2021 and has held it in 5 quarters since. The position peaked at $7K in Q4 2021. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Tyler-Stone Wealth Management held 10 shares of Idexx Laboratories worth $4K as of Q4 2022.
  • Tyler-Stone Wealth Management left its Idexx Laboratories share count unchanged in Q4 2022.
  • Idexx Laboratories made up ﹤0.01% of Tyler-Stone Wealth Management's portfolio in Q4 2022, its #685 holding.
  • Tyler-Stone Wealth Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 5 quarters since.
  • Tyler-Stone Wealth Management's Idexx Laboratories position peaked at $7K in Q4 2021.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.